imm-1-104
immuneering
['imm-1-104', 'immuneering', 'milestone,(-milestones)']
today we announced positive initial phase 1 pk, pd &amp; safety data from our universal-ras program, imm-1-104, in a poster presentation at #aacr23, representing a major milestone for immuneering &amp; for cancer patients affected by #rasmutations. find details: 